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Purpose: During stimulated in vitro fertilization (IVF) cycle, up to 30% of the re-
covered oocytes are immature ones which have poor fertilization capacity; howev-
er, the precise influencing factors are largely unknown. Here, we analyzed the as-
sociation of oocyte immaturity with woman’s age in IVF cycles stimulated by 
single regimen. Materials and Methods: A total of one-hundred ninety five IVF 
cycles stimulated by recombinant FSH and GnRH antagonist protocol between 
2003 and 2009 were analyzed retrospectively. The mean age of women was 
34.2±4.0 (26-45 years). After triggering by exogenous hCG, an ultrasound-guided 
retrieval of oocytes was performed 35-36 hours later. All clinical data were strati-
fied by woman’s age; group I: ≤30 (n=36), II: 31-35 (n=83), III: 36-40 (n=57), and 
IV: ≥41 (n=19). Results: The total retrieved oocytes, as well as immature oocytes, 
were significantly lower in group IV, however, the mean % of immature oocytes 
was significantly higher in group IV than other age groups. Oocyte immaturity 
tended to decrease as increasing age in women aged 40 years or less. Conclusion: 
In stimulated IVF cycle, much higher oocyte immaturity was noted in women 
aged 41 years or more.
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INTRODUCTION
During stimulation of in vitro fertilization (IVF) cycle, up to 30% of the recovered 
oocytes are immature ones.1-7 Reducing yield of immature oocytes is an another 
important aspect in stimulated IVF cycles because they usually have lower matu-
ration capacity and seldom yield transferable embryos.6 In clinical practice, im-
proving developmental competence of these rescued oocytes in vitro would be 
useful for women who yield only immature oocytes or show total fertilization fail-
ure of in vivo matured oocytes in stimulated IVF cycles.8-12
It is unclear why oocytes remain immature despite adequate ovarian stimulation. 
The immature oocytes may originate from small antral follicles at the time of oo-
cyte retrieval or from large preovulatory follicles which do not respond to hCG ap-Hee Jun Lee, et al.
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35-36 hours later. The collected cumulus-oocyte complexes   
were assessed by the presence or absence of a germinal vesi-
cle (GV) or the first polar body (PB) by stereomicroscope 
(×200). In situation of unclear maturity, the oocytes were 
sometimes denuded by using 85 IU/mL hyaluronidase 
(Cook) and mechanical pipetting.
Immature oocytes were defined as oocytes that appeared 
arrested at either prophase I (oocytes with GV) or meta-
phase I (evidence of GV breakdown but no PB visible). Im-
mature oocytes were then cultured in commercial IVM me-
dium (Cook-BL; Cook, Brisbane, Australia) supplemented 
with rFSH 75 mIU/mL (Serono), rhCG 0.5 IU/mL (Serono) 
and rEGF 10 ng/mL (Invitrogen, Carlsbad, CA, USA). All 
immature oocytes were cultured in 1 mL each of IVM me-
dium up to 48 hours in an atmosphere of 5% CO2 and 95% 
air with high humidity. After IVM, they were stripped with 
85 IU/mL hyaluronidase and mechanical pipetting until 
completely denuded of their cumulus cells. If matured, they 
were then fertilized by conventional insemination as the 
same method in in vivo matured oocytes. Normal fertiliza-
tion was confirmed when two distinct pronuclei were pres-
ent 16-18 hours later. Embryo culture was performed as de-
scribed previously.6
All data in the present study were analyzed using SPSS 
(Windows version 12.0). The Chi square test was used to 
compare two proportions. Since all data from four age groups 
showed a normal distribution, we used the parametric ANO-
VA test to compare the means within four groups; when a 
significant difference identified, the Scheffe Post Hoc test 
was applied. A p-value of <0.05 (two-tailed) was always 
considered statistically significant.
RESULTS
As shown in Table 1, causes of infertility, mean body mass 
index, and basal FSH level were not different between the 
four age groups. The mean antral follicle count was lowest 
in group IV, which was significantly different from that of 
group II. The dose of exogenous gonadotropins (ampoules) 
tended to be higher in group IV, but serum estradiol level at 
triggering day was similar in four groups. The fertilization 
rate of in vivo matured oocytes was similar among the four 
groups. The number of transferred embryos was lowest in 
group IV, and accordingly, the clinical pregnancy rate was 
significantly lower in group IV when compared with other 
age groups.
propriately. During ovarian stimulation, the oocyte popula-
tion at the time of hCG may be heterogeneous, leading to 
retrieval of oocytes at different stages of maturation. 
Currently, the mechanisms and the affecting factors to 
yield immature oocyte in stimulated IVF cycles are poorly 
understood. A high rate of oocyte immaturity was reported 
to be associated with young female age,5 the use of GnRH 
antagonist rather than GnRH agonist,4 and urinary hCG as a 
triggering agent rather than recombinant form.7 When all 
IVF cycles stratified were by two patient age groups (<35 
or ≥35 years), the incidence of abnormally higher oocyte 
immaturity (i.e. the cycles retrieving >50% immature oo-
cytes) was found to be significantly higher in <35 group 
than ≥35 group (8.5% vs. 1.4%).5 It has also been reported 
that urinary gonadotropin increases the yield of mature oo-
cytes in patients with a previous cycle having a high inci-
dence of oocyte immaturity by using recombinant FSH.7
We hypothesized that oocyte immaturity would be more 
common in older women undergoing stimulated IVF cycle 
because of their closer proximity to ovarian senescence and 
menopause. In the present study, we investigated the asso-
ciation between woman’s age and oocyte immaturity in 
IVF cycles stimulated by single regimen: i.e. recombinant 
FSH (rFSH) and GnRH antagonist.
MATERIALS AND METHODS
A total of 195 IVF cycles stimulated by rFSH and GnRH 
antagonist during a period between 2003 and 2009 were se-
lected. We obtained Institutional Review Board approval, 
although this was a retrospective comparative study. The 
mean age of women was 34.2±4.0 years with a range of 26-
45 years. The infertility factors were identified as the follow-
ing: tubal (n=56), unexplained (n=54), male (n=29), perito-
neal (n=19), age factor (n=16), uterine (n=12), and ovulatory 
(n=9).
Ovarian hyperstimulation was performed using rFSH 
(Gonal-F; Serono, Geneva, Switzerland) beginning on day 
3 of menstrual cycle. The pituitary was suppressed by flexi-
ble multiple-dose protocol of GnRH antagonist (Cetrotide; 
Serono). Follicular development was monitored with peri-
odic transvaginal ultrasounds and serum levels of estradiol. 
When dominant follicles averaged 19 mm in diameter, ovu-
lation was triggered by 5,000 IU of urinary hCG (Profasi; 
Serono) or 250 μg of recombinant hCG (Ovidrel; Serono). 
An ultrasound-guided retrieval of oocytes was performed Oocyte Maturity and Woman’s Age
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were immature ones in women aged 40 years or more.
DISCUSSION
   
In the present study, we attempted to investigated the rela-
tion between patient’s age and the rate of immature oocytes 
in IVF cycles. The oocyte immaturity was the highest in 
women aged 40 years or more; however, oocyte immaturity 
The mean number of total retrieved oocyte, as well as the 
number of immature oocyte, tended to decrease as increas-
ing age (Fig. 1). The resultant mean % of immature oocyte 
tended to be decreased as increasing age, however, this phe-
nomenon was observed only in women aged 40 years or less 
(37.9% in group I, 32.4% in group II, and 23.3% in group 
III, p>0.05). The mean % of immature oocyte was the high-
est in group IV with statistical significance, compared with 
group II and III. More than half of the retrieved oocytes 
Table 1. Clinical and Laboratory Characteristics of the Study Subjects according to Female Age Group
Group Group I (n=36) Group II (n=83) Group III (n=57) Group IV (n=19) p*
Range of age ≤30 31-35 36-40 ≥41
Body mass index (kg/m
2) 20.3±1.8 20.9±1.2 21.0±1.6 20.9±1.6 NS
Cause of infertility NS
    Unexplained 12 24 16 2
    Tubal 12 20 20 4
    Male   4 17   5 3
    Peritoneal   6   8   4 1
    Uterine   0   7   3 2
    Age   0   1   8 7
    Ovulatory   2   6   1 0
Basal FSH (mIU/mL)   6.0±2.5   5.2±5.2   4.1±2.1   9.2±8.5 NS
Antral follicle count   6.3±1.5     6.6±3.1 a   6.4±3.3      3.7±2.1 a 0.035
Exogenous gonadotropins (IU) 22.3±4.7   21.2±4.2 a 22.9±4.1    27.3±8.8 a 0.004
Endometrial thickness  on hCG day 
  (mm) 10.7±1.6 9.3±2.7   9.3±2.3   9.6±2.2 NS
E2 on hCG day (pg/mL) 1,425±528  1,533±1,202 1,251±986   570±375 NS 
ICSI cycle (%) 58.3 43.4 36.8 63.2 NS
Fertilization rate of in vivo matured 
  oocytes (%)   79.3±22.8 77.0±27.9   74.2±28.6   66.7±47.1 NS
No. of embryo transferred    2.4±0.7    2.5±0.9 a   2.4±0.9      1.8±1.3 a 0.050
Clinical pregnancy rate (%)    47.2 a    37.5 b    39.3 c            5.3 a,b,c 0.019
Ongoing pregnancy rate (%)    33.3 a    32.5 b    30.4 c         0 a,b,c 0.034
*ANOVA test with Scheffe’s post-hoc test; same superscript means p<0.05 for each other within same row. 
NS, not significant.
Fig. 1. (A) The mean number of total retrieved oocytes (group I: ≤30 years old, II: 31-35 years, III: 36-40 years, IV: ≥41 years) (I-IV: p=0.001, II-IV: p=0.000, III-IV: 
p=0.048, ANOVA test with Scheffe’s post-hoc test). (B) The mean number of immature oocytes (I-III: p=0.044, I-IV: p=0.008, II-IV: p=0.045). (C) The mean per-
centage of immature oocytes (II-IV: p=0.049, III-IV: p=0.002). 
0 0 0
2 0.5
1
10
4
1.5
20
6
2
30
8
2.5
40
10 3 50
12 3.5 60
M
e
a
n
 
n
u
m
b
e
r
M
e
a
n
 
n
u
m
b
e
r
M
e
a
n
 
p
e
r
c
e
n
t
 
(
%
)
Group I Group I Group I Group II Group II Group II Group III Group III Group III Group IV Group IV Group IV
9.25
3.31
37.9
9.57
3.16
32.4
7.02 2.14
23.3
2.84
1.53
52.5
A B CHee Jun Lee, et al.
Yonsei Med J   http://www.eymj.org   Volume 53   Number 1   January 2012 184
ty was similar between hCG-containing highly purified 
HMG and rFSH; 69% vs. 67.4%,15 and 71.2% vs. 70.8%.16 
Urinary HMG also yielded a similar rate of mature oocyte 
compared with rFSH; 89.3% vs. 86.2%.17 Even significantly 
less mature oocyte was reported by using urinary HMG 
compared with highly purified FSH; 80.6% vs. 88.8%.18 
Therefore, currently available evidence does not support 
the superiority of gonadotropins including LH content, in 
terms of oocyte maturity.
GnRH antagonist protocol appears to have a better chance 
to obtain immature oocytes compared with GnRH agonist 
protocol.4 This may be due to greater heterogeneity in folli-
cle development in patients receiving antagonist protocol.19 
In the present study, we selected single stimulation regimen 
(rFSH only with GnRH antagonist protocol) to eliminate 
possible confounding effect from variable regimens. 
In conclusion, the rate of immature oocyte was not pro-
portional to woman’s age; it was the highest in women ≥41 
years, followed by young women ≤30 years. Further re-
searches are needed regarding the identification of influenc-
ing factors and the mechanisms for oocyte immaturity de-
spite adequate ovarian stimulation. Furthermore, efforts 
should be continued to reduce its incidence in stimulated 
IVF cycle.
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